Health News Roundup: Japanese authorities inspect second Kobayashi Pharma factory after deaths; Russian military intelligence unit may be linked to 'Havana syndrome', Insider reports and more

It was the second case of the H5N1 strain of avian influenza, commonly known as bird flu, identified in a person in the United States, following a 2022 case in Colorado, and comes as the virus is spreading to new mammals including dairy cattle for the first time. Japanese authorities inspect second Kobayashi Pharma factory after deaths Health authorities searched a second Kobayashi Pharmaceutical factory in western Japan on Sunday after the company reported five deaths possibly tied to dietary supplements, an official said.


Devdiscourse News Desk | Updated: 02-04-2024 11:46 IST | Created: 02-04-2024 10:31 IST
Health News Roundup: Japanese authorities inspect second Kobayashi Pharma factory after deaths; Russian military intelligence unit may be linked to 'Havana syndrome', Insider reports and more
Representative Image

Following is a summary of current health news briefs.

Nigerian takes to the water to raise mental health awareness

Nigerian swimmer Akinrodoye Samuel has tried to raise awareness on mental health in Africa's most populous nation, swimming nearly 12 km (7.45 miles), the length of the longest bridge in Lagos where many people have jumped to their deaths. Samuel, a swimming coach, said he was moved by the experience of a friend who nearly took his own life due to depression.

Russian military intelligence unit may be linked to 'Havana syndrome', Insider reports

The mysterious "Havana syndrome" ailment that has afflicted U.S. diplomats and spies across the world may be linked to energy weapons wielded by members of a Russian military intelligence sabotage unit, the Insider media group reported. A U.S. intelligence investigation whose findings were released last year found that it was "very unlikely" a foreign adversary was responsible for the ailment, first reported by U.S. embassy officials in the Cuban capital Havana in 2016.

Healthcare firm PACS Group eyes up to $3.25 billion valuation in US IPO

PACS Group said it is seeking a valuation of as much as $3.25 billion in its U.S. initial public offering, the latest in a string of firms looking to take advantage of improving investor interest for new stocks. After a two-year dry spell, IPOs in the United States are expected to rebound in 2024 on firming bets of a soft landing for the country's economy and a broad rally in the capital markets.

South Korea's Yoon urges doctors to end impasse over trainees

South Korean President Yoon Suk Yeol said on Monday his government is open to talks with doctors who oppose his plan to increase medical school admissions, while accusing critics of offering no reasonable alternative to ease a doctor shortage. In a 50-minute address to the country, Yoon signalled his willingness for the first time to seek a compromise on his medical reform proposals after the government called for dialogue with striking doctors.

Florida top court allows for near-total abortion ban; says voters can decide issue in November

Florida's top court on Monday cleared the way for a Republican-backed law banning abortion after six weeks of pregnancy to take effect, but also approved an initiative to let voters decide whether to amend the state's constitution to establish a right to an abortion. In a pair of rulings, the Florida Supreme Court upheld an existing law that banned abortion after 15 weeks, and by doing so, cleared the way for a six-week ban to take effect.

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance to clear a path to launch cheaper generic versions of the medicine. The U.S. Court of Appeals for the Federal Circuit said that the last remaining J&J patent covering its Invega Sustenna may be invalid, sending the case back for a New Jersey federal court to reconsider.

Biden administration US ban on menthol cigarettes delayed

The U.S. Food and Drug Administration's proposal to ban menthol-flavored cigarettes in the United States faced another setback, according to anti-tobacco advocates who noted that White House officials have missed another deadline to issue a final rule on a ban. The White House declined to comment.

Fitch says UnitedHealth unit hack to have no credit impact on not-for-profit hospitals

Fitch does not anticipate any credit impact on not-for-profit hospitals in the United States from the cyberattack at UnitedHealth's tech unit Change Healthcare that disrupted pharmacies across the U.S., the rating agency said on Monday. The agency said it does not see any negative rating implications tied to the hack if the care providers can return to normal operations in the near term and maintain a large enough cash cushion.

Texas, CDC say bird flu detected in person exposed to dairy cattle

Texas and the U.S. Centers for Disease Control and Prevention (CDC) on Monday reported a case of avian influenza in a person who had contact with dairy cows presumed to be infected with the virus. It was the second case of the H5N1 strain of avian influenza, commonly known as bird flu, identified in a person in the United States, following a 2022 case in Colorado, and comes as the virus is spreading to new mammals including dairy cattle for the first time.

Japanese authorities inspect second Kobayashi Pharma factory after deaths

Health authorities searched a second Kobayashi Pharmaceutical factory in western Japan on Sunday after the company reported five deaths possibly tied to dietary supplements, an official said. The inspection in Wakayama prefecture follows one on Saturday in Osaka, expanding the investigation into the drugmaker's use of "Beni-Koji" red yeast materials.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback